1-5 of 5
Ralph D’Agostino
Close
Sort by
Journal Articles

Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study.

Selim Corbacioglu, MD, Simone Cesaro, MD, Maura Faraci, MD, Dominique Valteau-Couanet, MD, PhD, Bernd Gruhn, MD, Jaap Jan Boelens, MD, PhD, Cornelio Uderzo, MD, Netty Hewitt, Johanna Schrum, MD, Ingo Mueller, MD, Ansgar S Schulz, MD, Jerry Stein, MD, Robert Wynn, MRCP, FRCPath, MD, Johann Greil, MD, Susanne Matthes, MD, Sykora Karl-Walter, MD, Monika Fuehrer, MD, Anne O'Meare, MD, Klaus-Michael Debatin, MD, Joseph Massaro, PhD, Ralph D'Agostino, PhD, Margeret Hoyle, Massimo Iacobelli, MD, Christina Peters, MD, Giorgio Dini, MD
Journal: Blood
Blood (2009) 114 (22): 653.
https://doi.org/10.1182/blood.V114.22.653.653
Published: 2009
Journal Articles

Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.

Paul Richardson, M.D., Marcie Tomblyn, MD, MS, Nancy Kernan, M.D., Joel A. Brochstein, MD, Shin Mineishi, MD, Amanda Termuhlen, MD, Sally Arai, MD, Stephan A. Grupp, MD, PhD, Eva Guinan, M.D., Paul L. Martin, MD, PhD, Selim Corbacioglu, MD, Ernst Holler, M.D., Ralph D'Agostino, Ph.D., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, M.D., Robert J Soiffer, MD
Journal: Blood
Blood (2009) 114 (22): 654.
https://doi.org/10.1182/blood.V114.22.654.654
Published: 2009
Journal Articles

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator

Yan Jiao, John Wilkinson, IV, Xiumin Di, Wei Wang, Heather Hatcher, Nancy D. Kock, Ralph D'Agostino, Jr, Mary Ann Knovich, Frank M. Torti, Suzy V. Torti
Journal: Blood
Blood (2009) 113 (2): 462–469.
https://doi.org/10.1182/blood-2008-05-155952
Published: 2009
Includes: Supplemental data
Journal Articles

High Dose Cytarabine and Clofarabine (HiDAC → CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

Bayard Powell, Ralph D’Agostino, Jr., PhD, Denise Levitan, MD, Leslie Renee Ellis, MD, Susan Lyerly, PA-C, Megan Skiles, PA-C, Megan Manuel, NP, Robin Harrelson, RN, Claire Kimbrough, David Duane Hurd, MD
Journal: Blood
Blood (2008) 112 (11): 1936.
https://doi.org/10.1182/blood.V112.11.1936.1936
Published: 2008
Journal Articles

A Phase 3 Randomized, Historically-Controlled Clinical Trial Investigating the Use of Defibrotide in the Treatment of Severe Veno-Occlusive Disease Post-SCT: A Novel Approach to the Validation of a Promising New Drug for the Treatment of a Life Threatening Disease.

Paul Richardson, Nancy Kernan, Marcie Tomblyn, Paul Martin, Sally Arai, Joel Brochstein, Eva Guinan, Gideon Steinbach, Elizabeth Nemecek, Ralph D’Agostino, Carolyn Revta, Alison Hannah, Massimo Iacobelli, Robert Soiffer
Journal: Blood
Blood (2007) 110 (11): 614.
https://doi.org/10.1182/blood.V110.11.614.614
Published: 2007